Viewing data from Pull 25
captured on May 02, 2026 at 11:41 UTC
2 versions available
Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV